Market revenue in 2023 | USD 941.7 million |
Market revenue in 2030 | USD 1,535.9 million |
Growth rate | 7.2% (CAGR from 2023 to 2030) |
Largest segment | Formulation development |
Fastest growing segment | Formulation Development |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Preformulation, Formulation Development |
Key market players worldwide | SGS, Intertek Group PLC, Recipharm, Lonza Group Ltd, Charles River Laboratories International Inc, Eurofins Scientific SE, Element Solutions Inc, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, Catalent Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to formulation development outsourcing market will help companies and investors design strategic landscapes.
Formulation development was the largest segment with a revenue share of 76.82% in 2023. Horizon Databook has segmented the Italy formulation development outsourcing market based on preformulation, formulation development covering the revenue growth of each sub-segment from 2018 to 2030.
According to the La Gazzetta del Mezzogiorno, the contract manufacturing industry in the country grew by nearly 40%, mainly due to rise in exports, making Italy one of Europe’s leading nations in terms of Contract Development and Manufacturing Organizations (CDMO) market.
Furthermore, it is estimated that there are over 150 CDMOs in Italy. These CDMOs provide a wide range of services to the pharmaceutical and biotech industries, including drug formulation development and clinical trial supports.
In November 2022, Italian biotech and contract manufacturing company ReiThera opened a new CDMO facility expansion worth USD 14.6 million for the production of large-scale viral vectors used in vaccines and gene therapies, also involved in vaccine formulation developments. Similarly, other CDMO companies such as Fisiopharma S.r.l offers complex drug formulation development outsourcing services for over 30 years.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy formulation development outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into Italy formulation development outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account